Caricamento...
Potential role of ixekizumab in the treatment of moderate-to-severe plaque psoriasis
BACKGROUND: Psoriasis is a debilitating autoimmune skin disease that affects 2%–3% of the world’s population. Patients with moderate-to-severe plaque psoriasis suffer from a decreased quality of life as well as comorbidities. Newer biological agents have been shown to be more effective than traditio...
Salvato in:
| Autori principali: | , |
|---|---|
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
Dove Medical Press
2013
|
| Soggetti: | |
| Accesso online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3600940/ https://ncbi.nlm.nih.gov/pubmed/23515267 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/CCID.S42424 |
| Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !
|